LCII
LCI Industries
LCII has the edge over TSLA overall, supported by stronger valuation and lower modeled downside.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
LCII Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
LCII's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
LCII PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $78.22 | -19% |
| Current | 12x | $96.99 | — |
| Fair | 16x | $132 | +36% |
| Expensive | 26x | $212 | +119% |
Historical ranges are pointers, not guarantees.
LCII has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
LCII Forward outlook
There aren't enough analyst estimates for LCII to show an outlook.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
LCII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $8.12 | +14% |
| Q2 2026 | $8.62 | +44% |
| Q1 2026 | $8.16 | +34% |
| Q4 2025 | $7.57 | +35% |
| Q3 2025 | $7.15 | +39% |
| Q2 2025 | $5.99 | +26% |
| Q1 2025 | $6.10 | +66% |
| Q4 2024 | $5.60 | +122% |
LCII has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
LCII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $992.5M | -4.2% |
| Q2 2026 | $968.7M | -13% |
| Q1 2026 | $1.1B | +4.3% |
| Q4 2025 | $932.7M | +16% |
| Q3 2025 | $1B | +13% |
| Q2 2025 | $1.1B | +5% |
| Q1 2025 | $1B | +8% |
| Q4 2024 | $803.1M | -4.1% |
LCII has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | +0.3 points |
| Q2 2026 | 9.9% | +2 points |
| Q1 2026 | 8.7% | +1 points |
| Q4 2025 | 3.8% | +1.8 points |
| Q3 2025 | 7.3% | +1.4 points |
| Q2 2025 | 7.9% | -0.7 points |
| Q1 2025 | 7.8% | +1.8 points |
| Q4 2024 | 2% | +1.7 points |
LCII has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
LCII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $53.6M | -34% |
| Q2 2026 | $184.9M | +86% |
| Q1 2026 | -$43.1M | -228% |
| Q4 2025 | $64.3M | -33% |
| Q3 2025 | $80.9M | +18% |
| Q2 2025 | $99.5M | -45% |
| Q1 2025 | $33.7M | +$49.9M |
| Q4 2024 | $95.7M | -24% |
LCII still generates free cash flow, though less than at its 2026 peak: $260M over the past year.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
LCII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +25K shares |
| 1 year | -0.2% | -49K shares |
| 3 years | -4.3% | -1.1M shares |
| 5 years | -3.9% | -1M shares |
| Available history | -2.7% | -676K shares |
LCII has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $62.2M |
| Q2 2025 | $38.1M |
| Q1 2025 | $28.3M |
LCII hasn't bought back shares in the past year.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
LCII Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.7x | Healthy |
LCII's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.0 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over LCII on leverage, with a lower net debt burden relative to earnings.
LCII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 63.9 | Neutral |
LCII's weekly RSI is 49 (neutral) and its Stochastic is 64 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
LCII PE vs Consumer Cyclical Sector
| Metric | LCII | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 34% below |
| PE % | 23 | 47 | 24 pts below |
LCII has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
LCII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.5 | 9.6% above |
| 20 week MA | $96.3 | 0.7% above |
| 50 week MA | $112.3 | 14% below |
| 100 week MA | $104.4 | 7.1% below |
| 200 week MA | $109.8 | 12% below |
LCII has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 12% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over LCII on trend strength, trading above more of its moving averages.
LCII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.7 | $134.3 | +24% |
| 2021 | $134.3 | $149.9 | +12% |
| 2022 | $149.9 | $94.8 | -37% |
| 2023 | $94.8 | $125.7 | +33% |
| 2024 | $125.7 | $102.7 | -18% |
| 2025 | $102.7 | $123.7 | +20% |
| 2026 YTD | $123.7 | $97.0 | -22% |
LCII has finished higher in four of the last six years. It's down 22% so far in 2026.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over LCII on returns for 2026, with the stronger performance.